Invesco Ltd. Burning Rock Biotech LTD Transaction History

Invesco Ltd.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$2.15 - $3.16 $29,504 - $43,364	-13,723 Reduced 21.13%	51,219 $110,000
Q1 2023 May 12, 2023	SELL	$2.16 - $3.47 $9,288 - $14,921	-4,300 Reduced 6.21%	64,942 $182,000
Q4 2022 Feb 13, 2023	SELL	$1.73 - $2.95 $13,499 - $23,018	-7,803 Reduced 10.13%	69,242 $155,000
Q3 2022 Nov 14, 2022	BUY	$2.39 - $3.96 $4,584 - $7,595	1,918 Added 2.55%	77,045 $184,000
Q2 2022 Aug 15, 2022	BUY	$1.75 - $10.44 $25,406 - $151,567	14,518 Added 23.95%	75,127 $219,000
Q1 2022 May 16, 2022	BUY	$6.7 - $10.23 $152,793 - $233,295	22,805 Added 60.32%	60,609 $563,000
Q4 2021 Feb 14, 2022	BUY	$9.43 - $17.14 $11,476 - $20,859	1,217 Added 3.33%	37,804 $360,000
Q3 2021 Nov 15, 2021	BUY	$17.37 - $27.92 $195,742 - $314,630	11,269 Added 44.51%	36,587 $655,000
Q2 2021 Aug 17, 2021	BUY	$26.14 - $37.45 $89,058 - $127,592	3,407 Added 15.55%	25,318 $746,000
Q1 2021 May 17, 2021	BUY	$23.5 - $39.58 $199,585 - $336,152	8,493 Added 63.3%	21,911 $590,000
Q4 2020 Feb 16, 2021	BUY	$22.55 - $30.87 $302,575 - $414,213	13,418 New	13,418 $310,000

21.2K

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $642M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.